Metabolism and toxicity of diisopropylnaphthalene as compared to naphthalene and monoalkyl naphthalenes: A minireview

Toxicology

Volumn 126, Issue 1, 1998, Pages 1-7

  Höke, Hartmut ^a   Zellerhoff, Robert ^b  

^a Im Langgewann 11   (Germany)

^b Rütgers Kureha Solvents GmbH   (Germany)

Author keywords

1 Methylnaphthalene Cas No. 90 12 0 ; 2,6 Diisopropylnaphthalene Cas No. 24157 81 1 ; 2 Methylnaphthalene Cas No. 91 57 6 ; Alkylated naphthalene; Alkylation; Aromatic substance; Diisopropylnaphthalene (mixture of isomers) Cas No. 38640 62 9 ; Metabolism; Naphthalene Cas No. 90 20 3 ; Toxicity

Indexed keywords

DIISOPROPYLNAPHTHALENE; NAPHTHALENE; NAPHTHALENE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; LUNG TOXICITY; MAMMAL; METABOLISM; MOUSE; NONHUMAN; OXIDATION; PRIORITY JOURNAL; RAT;

ANEMIA, HEMOLYTIC; ANIMALS; CATARACT; HUMANS; LUNG; NAPHTHALENES; NECROSIS;

ANIMALIA; MAMMALIA;

EID: 0344074486     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-483X(97)00187-X     Document Type: Article

References (34)

1. BUA (Beratergremium für umweltrelevante Altstoffe)/GDCh, 1989. Naphthalene, BUA-Report 39. VCH, Weinheim.
2. BUA (Beratergremium für umweltrelevante Altstoffe)/GDCh, 1990. Methylnaphthalene, BUA-Report 47. VCH, Weinheim.
3. Buckpitt A.R., Castagnnoli J., Nelson S.D., Jones A.D., Bahnson L.S. Stereoselectivity of naphthalene epoxidation by mouse, rat, and hamster pulmonary, hepatic and renal microsomal enzymes. Drug Metab. Dispos. 15:1987;491-498.
4. Buckpitt A.R., Franklin R.B. Relationship of naphthalene and 2-methylnaphthalene metabolism to pulmonary bronchiolar epithelial cell necrosis. Pharmacol. Ther. 41:1989;393-410.
5. Buckpitt A.R., Buonaroti M., Avey L.B., Chang A.-M., Morin D., Plopper C.G. Relationship of cytochrome P450 activity to Clara cell cytotoxicity. II. Comparison of stereoselectivity of naphthalene epoxidation in lung and nasal mucosa of mouse, hamster, rat, and rhesus monkey. J. Pharmacol. Exp. Ther. 261:1992;364-372.
6. Buckpitt A., Chang A.-M., Weir A., van Winkle L., Duan X., Philpot R., Plopper Ch. Relationship of cytochrome P450 activity to Clara cell cytotoxicity. IV. Metabolism of naphthalene and naphthalene oxide in microdissected airways from mice, rats, and hamsters. Mol. Pharmacol. 47:1995;74-81.
7. Griffin K.A., Johnson C.B., Breger R.K., Franklin R.B. Pulmonary toxicity, hepatic and extrahepatic metabolism of 2-methylnaphthalene in mice. Toxicol. Appl. Pharmacol. 61:1981;185-196.
8. Griffin K.A., Johnson C.B., Breger R.K., Franklin R.B. Effects of inducers and inhibitors of cytochrome P-450-linked monooxygenases on the toxicity, in vitro metabolism and in vivo irreversible binding of 2-methylnaphthalene in mice. J. Pharmacol. Exp. Ther. 221:1982;517-524.
9. Griffin K.A., Johnson C.B., Breger R.K., Franklin R.B. Pulmonary toxicity of 2-methylnaphthalene: lack of relationship between toxicity, dihydrodiol formation and irreversible binding to cellular macromolecules in DBA/2J mice. Toxicology. 26:1983;213-230.
10. Grimes A.J., Young L. The metabolism of 2-methylnaphthalene. Biochem. J. 62:1956;11P.
11. Honda T., Fukada A., Kiyozumi M., Kojima S. Identification and determination of urinary metabolites of 2-isopropylnaphthalene in rabbits. Eur. J. Drug Metabol. Pharmocokin. 12:1987;11-16.
12. Honda T., Kiyozumi M., Kojima S. Alkylnaphthalene. XI. Pulmonary toxicity of naphthalene, 2-methylnaphthalene, and isopropylnaphthalenes in mice. Chem. Pharm. Bull. 38:1990;3130-3135.
13. Kojima S., Nakagawa M., Suzuki R., Horio M., Tanaka R. Alkylnaphthalenes: I. Absorption, tissue distribution and excretion of 2,6-diisopropylnaphthalene administered continuously to rats. Chem. Pharm. Bull. 26:1978;3007-3009.
14. Kojima S., Nakagawa M., Suzuki R., Horio M., Taniguchi Y., Tanaka R. Alkylnaphthalenes: II. Tissue accumulation of 2,6-diisopropylnaphthalene administered continuously to rats (in English). Eisei Kagaku. 25:1979;221-224.
15. Kojima S., Honda T., Nakagawa M., Kiyozumi M., Takadate A. Urinary metabolites of 2,6-diisopropylnaphthalene in rats. Drug Metab. Dispos. 10:1982;429-433.
16. Kojima S., Honda T., Babasaki T., Kiyozumi M., Nakagawa M. Identification and determination of urinary and biliary metabolites of 2-isopropylnaphthalene in rats (in English). Eisei Kagaku. 30:1984;91-95.
17. Kojima S., Honda T., Kiyozumi M. Biliary metabolites of 2,6-diisopropylnaphthalene in rats. Bull. Environ. Contam. Toxicol. 35:1985;745-749.
18. IIE1: protection with diethyldithiocarbamate administration. Chem. Biol. Interact. 81:1992;271-289.
19. MAK, 1995. Arbeitsmedizinisch-toxikologische Begründungen von MAK-Werten, vol. 21, Naphthalin. Deutsche Forschungsgemeinschaft, VCH, Weinheim.
20. Melancon M.J., Rickert D.E., Lech J.J. Metabolism of 2-methylnaphthalene in the rat in vivo. I. Identification of 2-naphthoglycine. Drug Metab. Dispos. 10:1982;128-133.
21. Nagata K., Martin B.M., Gillette J.R., Sasame H.A. Isoenzymes of cytochrome P-450 that metabolize naphthalene in liver and lung of untreated mice. Drug Metab. Dispos. 18:1990;557-564.
22. O'Brien K.A.F., Smith L.L., Cohen G.M. Differences in naphthalene-induced toxicity in the mouse and rat. Chem.-Biol. Interact. 55:1985;109-122.
23. O'Brien K.A.F., Suverkropp C., Kanekal S., Plopper C.G., Buckpitt A.R. Tolerance to multiple doses of the pulmonary toxicant, naphthalene. Toxicol. Appl. Pharmacol. 99:1989;487-500.
24. Pike M.H. Ocular pathology due to organic compounds. J. Michigan State Med. Soc. 43:1944;581-584.
25. Plopper C.G., Suverkropp C., Morin D., Nishio S., Buckpitt A.R. Relationship of cytochrome P-450 activity to clara cell cytotoxicity: I. Histopathological comparison of the respiratory tract of mice, rats, and hamster after parenteral administration of naphthalene. J. Pharmacol. Exp. Ther. 261:1992;353-363.
26. Reid W.D., Ilett K.F., Glick J.M., Krishna G. Metabolism and binding of aromatic hydrocarbons in the lung. Am. Rev. Respir. Dis. 107:1973;539-551.
27. Smart G., Buckpitt A.R. Formation of reactive naphthalene metabolites by target vs. non-target tissue microsomes: methods for the separation of three glutathione adducts. Biochem. Pharmacol. 32:1983;943-946.
28. Teshima R., Nagamatsu K., Ikebuchi H., Kido Y., Terao T. In vivo and in vitro metabolism of 2-methylnaphthalene in the guinea pig. Drug Metab. Dispos. 11:1983;152-157.
29. Valaes T., Doxiadis S.A., Fessas Ph. Acute hemolysis due to naphthalene inhalation. J. Pediatr. 63:1963;904-915.
30. Van Bladeren P.J., Vyas K.P., Sayer J.M., Ryan D.E., Thomas P.E., Levin W., Jerina D.M. Stereoselectivity of cytochrome P-450 in the formation of naphthalene and anthracene-1,2-oxides. J. Biol. Chem. 259:1984;8966-8973.
31. Van Heyningen R. Naphthalene cataract in rats and rabbit: a resumé Exp. Eye Res. 28:1979;435-439.
32. Warren D.L., Brown D.L., Buckpitt A.R. Evidence for cytochrome P-450 mediated metabolism in the bronchiolar damage by naphthalene. Chem.-Biol. Interact. 40:1982;287-303.
33. Zinkham W.H., Childs B. A defect of glutathion metabolism in erythrocytes from patients with a naphthalene-induced hemolytic anemia. Pediatrics. 9:1958;461-471.
34. Zuelzer W.W., Apt L. Acute hemolytic anemia due to naphthalene poisoning. J. Am. Med. Assoc. 141:1949;185-190.